This is a preview of subscription content, log in via an institution to check access.
References
Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511–521.
Santos SC, Dias S . Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signalling pathways. Blood 2004; 103: 3883–3889.
Bellamy WT, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001; 97: 1427–1434.
Fragoso R, Pereira T, Wu Y, Zhu Z, Cabeçadas J, Dias S . VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood 2006; 107: 1608–1616.
Dias S, Shmelkov SV, Lam G, Raffi S . VEGF165 promotes survival of leukemic cells by Hsp90-mediated inductin of Bxl-2 expression and apoptosis inhibition. Blood 2002; 99: 2532–2540.
Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP . Identification of peptide and protein ligands for the caveolin-scaffolding domain. J Biol Chem 1997; 272: 6525–6533.
Rautonen J, Hovi L, Siimes MA . Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood 1998; 71: 989–991.
Masson Gadais B, Houle F, Laferriere J, Huot J . Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/P38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF. Cell Stress Chaperones 2003; 8: 37–52.
Acknowledgements
This study was supported by FCT (Portuguese Government) fellowships (SFRH/BPD/5683/2001, attributed to CC, SFRH/BD/14162/2003, attributed to RF) and FCT Project grant (POCTI 39381/2001, Sérgio Dias). We thank other members of the Angiogenesis laboratory for their critical reading of the manuscript. We are also grateful to Isabel Marques of Institute Gulbenkian of Science for the search of caveolin-binding domains in FLT-1 human sequence.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Casalou, C., Fragoso, R., Nunes, J. et al. VEGF/PLGF induces leukemia cell migration via P38/ERK1/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation. Leukemia 21, 1590–1594 (2007). https://doi.org/10.1038/sj.leu.2404668
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404668
- Springer Nature Limited
This article is cited by
-
Role of FRG1 in predicting the overall survivability in cancers using multivariate based optimal model
Scientific Reports (2021)
-
Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma
Respiratory Research (2019)
-
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
BMC Cancer (2019)
-
A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target
Leukemia (2018)
-
Clustered precursors in bone marrow sections predict early relapse in patients with acute myeloid leukemia within hematologic remission
Journal of Translational Medicine (2014)